Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTP) Times Interest Earned (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Times Interest Earned for 4 consecutive years, with -$1361.5 as the latest value for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 5.73% to -$1361.5 in Q3 2025 year-over-year; TTM through Sep 2025 was $22.48, a 102.81% increase, with the full-year FY2024 number at -$211.15, down 9266.98% from a year prior.
  • Times Interest Earned was -$1361.5 for Q3 2025 at 60 Degrees Pharmaceuticals, down from -$1314.4 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $4204.8 in Q4 2024 to a low of -$1444.2 in Q3 2024.
  • A 4-year average of -$265.59 and a median of -$347.81 in 2023 define the central range for Times Interest Earned.
  • Biggest YoY gain for Times Interest Earned was 1308.95% in 2024; the steepest drop was 210549.87% in 2024.
  • 60 Degrees Pharmaceuticals' Times Interest Earned stood at $0.43 in 2022, then tumbled by 80441.89% to -$347.81 in 2023, then skyrocketed by 1308.95% to $4204.8 in 2024, then crashed by 132.38% to -$1361.5 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Times Interest Earned are -$1361.5 (Q3 2025), -$1314.4 (Q2 2025), and -$1067.5 (Q1 2025).